Patents were recently granted in 12 new countries for SULIDIN® LPS® (Topical Nimesulide Gel). Licensees are sought in these and other territories worldwide. More
Zambon and APR have recently signed a Strategic Alliance and License Agreement for the further development and marketing of innovative patented consumer oriented products in patch form. More
Questcor Pharmaceuticals has signed an agreement with Beacon Pharmaceuticals of Tunbridge Wells, Kent, UK, for the exclusive marketing and distribution of H.P. Acthar(R) Gel in the United Kingdom. More
Zambon and APR Applied Pharma Research S.A. have signed an international license agreement for the further development of innovative patented products in matrix patch form More
Rapid In-vitro Percutaneous Penetration Profile of Sulidin® 1% Nimesulide LPS topical gel to be presented at the 8'th International Conference on Percutaneous Penetration. More